$SNGX 3 SEC Filings

Filed On	Filing
05 May 2023	Form 3: Cote Timothy R., Director Holds 25,317 shares of Common Stock
11 Sep 2019	Form 3: Guarino Jonathan L., Senior Vice President and CFO No securities owned
08 Jul 2019	Form 3: Parks Diane L., Director No securities owned
25 Jul 2018	Form 3: Pearson Mark E., Director Holds 2,330,000 shares of COMMON STOCK
22 Jun 2016	Form 3: Krumeich Karen R, SVP and CFO Holds 13,000 shares of Common Stock
10 Dec 2014	Form 3: Donini Oreola, Senior Vice President and CSO
08 Jan 2014	Form 3: Straube Richard, Senior VP & CMO No securities owned
09 Dec 2013	Form 3: Brughera Marco Maria, Director No securities owned
26 Jun 2013	Form 3: Kirk Randal J, 10% owner and 1 other Holds 3,333,333 shares of Common Stock
24 Jun 2011	Form 3: Zeldis Jerome B, Director No securities owned
24 Jun 2011	Form 3: Brownlie Keith L, Director No securities owned
03 Jun 2011	Form 3: Warusz Joseph Michael, VP of Admin, Controller No securities owned
02 Feb 2011	Form 3: Horgan Kevin, Senior VP; Chief Med Officer No securities owned
27 Sep 2010	Form 3: Thompson Virgil, Director No securities owned
27 Sep 2010	Form 3: Howson Tamar D, Director No securities owned
20 Aug 2010	Form 3: Bam Management Llc, 10% owner and 2 others Holds 21,606,092 shares of Common Stock
13 Oct 2009	Form 3: Rubin Robert Joseph, Director No securities owned
09 Jul 2009	Form 3: Schnittker Christopher P, VP ADMIN CONTROLLER No securities owned
02 Jul 2009	Form 3: Biotex Pharma Investments, Llc, 10% owner Holds 20,000,000 shares of Common Stock, Par Value $0.001 per share
30 Mar 2009	Form 3: Brey Robert N, Chief Scientific Officer/SrVP No securities owned

Comments